Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Active Rheumatoid Arthritis
NCT00546533Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00546533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546533.